Hematology/Oncology

Top Story

FDA grants orphan drug designation to BPM31510 for pancreatic cancer

January 23, 2018
Meeting News

Pembrolizumab induces durable responses in advanced liver cancer

January 23, 2018
Pembrolizumab treatment led to durable OS and PFS among patients with advanced hepatocellular carcinoma who previously progressed on sorafenib, according to results of…
In the Journals PlusPerspective

Stem cell transplant maintains benefit for multiple myeloma in era of novel agents

January 23, 2018
Treatment with high-dose melphalan followed by autologous hematopoietic stem cell transplant conferred longer PFS with minimal toxic effects compared with novel agents…

CHIP funding renewed for 6 years

January 23, 2018
After 4 months without a permanent solution for funding, the Children’s Health Insurance Program received monetary support for the next 6 years on Monday, Jan…

Lymphadenectomy may not add benefit in high-risk renal cell carcinoma

January 23, 2018
Patients with high-risk renal cell carcinoma who undergo surgery may not benefit from lymphadenectomy, according to a secondary analysis of the randomized ASSURE…
More Headlines »
CME

Targeted Therapies for Metastatic HCC: Multidisciplinary Perspectives on the Latest Clinical Advances

This activity is supported by an educational grant from Bayer Healthcare Pharmaceuticals, Inc.

The incidence of hepatocellular carcinoma (HCC) continues to increase in the United States. Management of patients…
More »
Video
Meeting News

VIDEO: Letermovir CMV prophylaxis offers survival benefit in hematopoietic cell transplant patients

October 14, 2017
More »
Resource Centers
San Antonio Breast Cancer Symposium

San Antonio Breast Cancer Symposium

CME

Benefits and Challenges of Immunotherapy: An Interdisciplinary Perspective

This activity is supported by an educational grant from Bristol-Myers Squibb.

The integration of immunotherapies into management strategies for the treatment of numerous hard-to-treat malignancies…
More »
Current Issues
View the Current Issue
HemOnc Today